Health insurance stocks are rallying Tuesday after the federal government handed them a Medicare Advantage rate increase that’s better than expected — and just good enough to save a sector that’s been bleeding for months. The Centers for Medicare & Medicaid Services finalized a 2.48% rate hike for 2027, up from the initial proposal and enough to stabilize earnings for companies that had been bracing for disaster.
UnitedHealth Group surged more than 10% on the news. Humana, Elevance, and CVS all jumped as investors realized the worst-case scenario is off the table. The 2.48% increase is still lower than the 5.06% hike in 2026 and the 3.70% bump in 2025, but it’s enough to keep Medicare Advantage plans profitable — barely.
Raymond James analyst Chris Meekins summed it up: “A beaten-down industry is on the cusp of potentially two years of earnings growth.” That’s the setup Wall Street was waiting for. Health insurers have been getting crushed as medical costs spiked and reimbursement rates lagged. The 2027 rate gives them breathing room to manage margins without slashing benefits or exiting markets.
The stakes are massive. Medicare Advantage covers more than 30 million Americans and generates tens of billions in revenue for insurers. If the rate had come in weaker, companies would have been forced to cut supplemental benefits, raise premiums, or pull out of certain geographies entirely. The 2.48% hike keeps the program viable — and keeps the profit machine running.
This is a classic Washington fix: just enough to avoid a crisis, not enough to make anyone happy. But for investors, it’s a green light. Health insurers were priced for a train wreck. Now they’re priced for a slow grind higher. That’s a trade Wall Street can work with.
